Gerresheimer has purchased the IP of a new generation cartridge-based autoinjector from Midas Pharma.   This marks the start of a new strategic partnership comprising the development and marketing of the new generation autoinjector. The go-to-market approach for the autoinjector combines the complementary strengths of both companies – Gerresheimer as a solution provider for medical devices and primary packaging solutions, and Midas Pharma as experienced facilitator for global pharma projec...